Nanjing Vazyme Biotech Co., Ltd (688105.SS) — Stock Score Summary

Nanjing Vazyme Biotech Co., Ltd (688105.SS) has a MoatMap StockRank of 61/100 based on Quality (48/100), Value (56/100), and Momentum (42/100) factor scores. The current signal is HOLD. Nanjing Vazyme Biotech provides key biological reagents and enzymes. While it acts as a critical upstream gatekeeper for Chinese biopharma and CDMOs, post-COVID revenue normalization has created near-term earnings volatility.

Nanjing Vazyme Biotech Co., Ltd. develops and manufactures biological reagents, enzymes, and raw materials for molecular diagnostics, life science research, and gene sequencing. The company is one of the few domestic firms with independent enzyme engineering and directed evolution platforms, reducing reliance on imported raw materials. It is an upstream biotechnology leader with a highly diversified product portfolio serving the IVD and biopharma industries.

Key Financial Metrics

Price$1.93
Market Cap$1.1B
P/E (Forward)36.32
Price/Book1.82
Return on Equity-0.6%
Return on Invested Capital-0.3%
Debt/Equity26.56
Gross Margin67.2%
Operating Margin-2.5%
Revenue Growth12.5%
Dividend Yield3.8%
Free Cash Flow$4M

Nanjing Vazyme Biotech Co., Ltd operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Nanjing Vazyme Biotech Co., Ltd’s (688105.SS) StockRank?
MoatMap’s StockRank for Nanjing Vazyme Biotech Co., Ltd (688105.SS) is 61/100, with a Hold signal. It is a composite of Quality (48), Value (56), and Momentum (42) factor ranks across MoatMap’s 19,000+ stock universe.
Does Nanjing Vazyme Biotech Co., Ltd have an economic moat?
Nanjing Vazyme Biotech Co., Ltd (688105.SS) has a Quality factor score of 48/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Nanjing Vazyme Biotech Co., Ltd a buy, hold, or sell?
MoatMap’s current signal for Nanjing Vazyme Biotech Co., Ltd (688105.SS) is Hold, based on a StockRank of 61/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Nanjing Vazyme Biotech Co., Ltd in?
Nanjing Vazyme Biotech Co., Ltd (688105.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).
Browse all ranked stocks688105.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock